A small clinical trial published last week in the Journal of Psychopharmacology found that therapeutic doses of MDMA, in concert with psychotherapy, reduced the severity of most participants’ PTSD symptoms.

U.S. District Judge William Conley concluded that there was no legally valid reason to exclude medically necessary care for the workers and called some of the state’s arguments “unhinged from reality.”